The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Bioventus Inc. (“Bioventus” or “the Company”) (NASDAQ: BVS) for violations of the federal securities laws.

Investors who purchased the Company's shares pursuant and/or traceable to the Company’s initial public offering conducted on February 11, 2021 (the “IPO”) and/or between February 11, 2021 and November 21, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 13, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Bioventus was suffering from a liquidity crisis. The Company could not sustain its rebate practices. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company’s public statements throughout the IPO and class period were false and materially misleading. When the market learned the truth about Bioventus, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005847/en/